32 JAK-STAT signaling pathway The JAK-STAT signaling pathway is fundamental to immune regulation and plays key roles in infection defense, immune tolerance, and tumor surveillance
Nevertheless, the length of the treatment will be contingent upon your progress and objectives for your health
The following serological markers will be assessed: fasting insulin, C-peptide, fasting glucagon, fasting plasma glucose, 2-h postprandial glucose, glycated albumin, leptin, adiponectin, lipid profile (triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol), liver function, renal function, gastrin-17, motilin, 5-HT, DA, HbA1c, and cholecystokinin
Most healthcare providers recommend restarting at 2.5 mg weekly or one step below your previous maintenance dose, then gradually increasing every 4 weeks to minimize gastrointestinal side effects while restoring therapeutic benefits
For type 2 diabetes, tirzepatide starts at 2.5 mg subcutaneously once weekly for four weeks, then increases by 2.5 mg increments every four weeks as tolerated, per the Mounjaro prescribing information
